| Metric | შპს ფემილი ფარმ | სს საქართველოს ბანკი |
|---|---|---|
| Growth | ||
| Revenue | ₾5.0m₾3.9m | ₾2.32bn₾1.91bn |
| Revenue growth | 28.7% | 21.1% |
| Profitability | ||
| EBITDA | -₾7.3m-₾1.7m | — |
| EBITDA margin | -144.9%-42.6% | — |
| Net profit | -₾7.3m-₾1.7m | ₾1.33bn₾992.0m |
| Net margin | -144.9%-42.6% | 57.6%51.9% |
| Balance sheet | ||
| Total assets | ₾51.7m₾32.7m | ₾31.39bn₾28.37bn |
| Total equity | -₾10.1m-₾2.8m | ₾4.45bn₾3.79bn |
| ROE | — | 30.0%26.2% |